recombinant tissue-type plasminogen activator ( rt-pa ) , streptokinase ( sk ) , and anisoylated plasminogen-streptokinase activator complex ( apsac ) have salutary effects on mortality when administered to patients with evolving acute myocardial infarction ( mi ) .
C0038418
streptokinase
C0078956
anisoylated plasminogen-streptokinase activator complex